Low pH drinking water in individual households is strongly associated with the risk of type 1 diabetes, according to results of a study reported in the September issue of Diabetes Care.

Inhaled, rapid-acting, dry powder insulin (Exubera®) may be used as a convenient alternative to pre-prandial injections in patients with type 1 diabetes.

Monitoring nighttime blood pressure identifies patients with type 1 diabetes who are at increased risk for kidney disease.

Victorian scientists reveal strong evidence for a new therapeutic target in the fight against Type 2 Diabetes.

Overweight children with high levels of the hormone insulin in their blood are also likely to have high levels of homocysteine.

Atorvastatin 80 mg/day lowered low-density lipoprotein (LDL) cholesterol levels further than did pravastatin 40 mg/day, and it also reversed atherosclerosis as reflected by reduced carotid intima-media thickness (CIMT).

The only way of reducing microvascular disease currently is by maintaining tight glycemic control, flexible insulin management is one way to achieve it.

Specific genes have been identified that have the ability to develop into any of the 200.000 cells in the body.

Nanomized Insulin made of smaller particles and reduces number of daily injections.

New screening tool can identify “silent coronary artery disease at an early stage in patients with diabetes